Skip to main content

Support WBUR

Johnson & Johnson, Eli Lilly Pause COVID-19 Drug Trials

The phase 3 trial of Johnson & Johnson's COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant's "unexplained illness." (AP)
The phase 3 trial of Johnson & Johnson's COVID-19 vaccine candidate has been paused as the company investigates what it says is a study participant's "unexplained illness." (AP)

Support WBUR

Support WBUR

Listen Live